Alpha 2.0
Login Register
» Articles » PMID: 24445186

Multiple Myeloma and Second Malignancies

Overview
Journal Clin Lymphoma Myeloma Leuk
Publisher Elsevier
Specialty Oncology
Date 2014 Jan 22
PMID 24445186
Citations 4
Authors
Monika Engelhardt
Ralph Wasch
Ola Landgren
Martina Kleber
Affiliations
Soon will be listed here.
Citing Articles

The risk and survival of multiple myeloma as the second primary malignancy in a single Chinese center.

Zhao X, Ji J, Li Y, Cui Y, Sun Z, Qu X Transl Cancer Res. 2024; 13(6):2905-2912.

PMID: 38988923 PMC: 11231780. DOI: 10.21037/tcr-23-2336.

Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients.

Miles B, Mackey J Cureus. 2021; 13(7):e16372.

PMID: 34422458 PMC: 8366185. DOI: 10.7759/cureus.16372.

Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.

Engelhardt M, Ihorst G, Landgren O, Pantic M, Reinhardt H, Waldschmidt J Haematologica. 2015; 100(10):1340-9.

PMID: 26160877 PMC: 4591767. DOI: 10.3324/haematol.2015.127548.

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.

Engelhardt M, Terpos E, Kleber M, Gay F, Wasch R, Morgan G Haematologica. 2014; 99(2):232-42.

PMID: 24497560 PMC: 3912952. DOI: 10.3324/haematol.2013.099358.